These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 32433360

  • 21. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY, Chen C, Xu X, Lu Q.
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [Abstract] [Full Text] [Related]

  • 22. NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
    Ba B, Mayila A, Guo Y, Xu J, Xing S, Cao G.
    Int J Exp Pathol; 2022 Feb; 103(1):23-30. PubMed ID: 34802165
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Chen X, Jiang X, Cheng C, Chen J, Huang S, Xu M, Liu S.
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
    Guan P, Sun ZM, Wang N, Zhou J, Luo LF, Zhao YS, Ji ES.
    Life Sci; 2019 Sep 15; 233():116748. PubMed ID: 31412263
    [Abstract] [Full Text] [Related]

  • 29. Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K/AKT/mTOR pathway.
    Qin L, Fan S, Jia R, Liu Y.
    Pharmazie; 2018 Jun 01; 73(6):349-355. PubMed ID: 29880088
    [Abstract] [Full Text] [Related]

  • 30. (-)-Epicatechin induces physiological cardiac growth by activation of the PI3K/Akt pathway in mice.
    De Los Santos S, García-Pérez V, Hernández-Reséndiz S, Palma-Flores C, González-Gutiérrez CJ, Zazueta C, Canto P, Coral-Vázquez RM.
    Mol Nutr Food Res; 2017 Feb 01; 61(2):. PubMed ID: 27605464
    [Abstract] [Full Text] [Related]

  • 31. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
    Wang J, Fan S, Xiong Q, Niu Y, Zhang X, Qin J, Shi Y, Zhang L.
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug 31; 53(9):1189-1197. PubMed ID: 34357376
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
    Lu X, Fan Q, Xu L, Li L, Yue Y, Xu Y, Su Y, Zhang D, Wang L.
    PLoS One; 2015 Aug 31; 10(2):e0117400. PubMed ID: 25689721
    [Abstract] [Full Text] [Related]

  • 38. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
    Liu L, Zhao X, Pierre SV, Askari A.
    Am J Physiol Cell Physiol; 2007 Nov 31; 293(5):C1489-97. PubMed ID: 17728397
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
    Jin L, Zhou Y, Han L, Piao J.
    In Vitro Cell Dev Biol Anim; 2020 Feb 31; 56(2):112-119. PubMed ID: 31845077
    [Abstract] [Full Text] [Related]

  • 40. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.
    Cheng KC, Li Y, Chang WT, Chen ZC, Cheng JT, Tsai CC.
    J Food Drug Anal; 2019 Jan 31; 27(1):355-364. PubMed ID: 30648591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.